Rothschild & Co Asset Management US’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-5,125
Closed -$457K 600
2017
Q1
$457K Sell
5,125
-2,501
-33% -$206K 0.01% 527
2016
Q4
$540K Buy
7,626
+1,554
+26% +$116K 0.01% 508
2016
Q3
$480K Buy
6,072
+1,416
+30% +$121K 0.01% 467
2016
Q2
$423K Buy
4,656
+294
+7% +$24.9K 0.01% 459
2016
Q1
$371K Buy
4,362
+1,069
+32% +$79.5K 0.01% 389
2015
Q4
$260K Buy
+3,293
New +$259K ﹤0.01% 418

Other funds holding MJN

Rothschild & Co Asset Management US's MJN Position: Q2 2017 in Review

Rothschild & Co Asset Management US sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 5,125 shares — an estimated $457K sold.

Rothschild & Co Asset Management US first reported a position in MJN in Q4 2015 and held it in 6 quarters. The position peaked at $540K in Q4 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Rothschild & Co Asset Management US reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 5,125 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $457K.
  • Rothschild & Co Asset Management US first reported a position in Mead Johnson Nutrition Company in Q4 2015 and held it in 6 quarters.
  • Rothschild & Co Asset Management US's Mead Johnson Nutrition Company position peaked at $540K in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2017, filed 27 Jul 2017.